English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 22, 2026

InVera Medical receives CE Mark approval for new non-thermal vein infusion device
+ Pharmaceuticals
Patient Daily | Feb 22, 2026

Biopharma senior leaders face rising pressures amid organizational changes
+ Community
Patient Daily | Feb 21, 2026

Older adults increasingly consider cochlear implants for severe hearing loss
+ Pharmaceuticals
Patient Daily | Feb 20, 2026

Japanese study links specific genetic mismatch to increased risk after cord blood transplant
+ Pharmaceuticals
Patient Daily | Feb 20, 2026

Grip strength linked to lower mortality risk in older women
+ Pharmaceuticals
Patient Daily | Feb 20, 2026

Trump administration unveils Great Healthcare Plan with changes impacting Californians in 2026
+ Pharmaceuticals
Patient Daily | Feb 20, 2026

Experts warn about overlooked risks of delirium after heart procedures
+ Pharmaceuticals
Patient Daily | Feb 20, 2026

Screening linked to earlier detection rates for colorectal cancer in large Swedish study

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones